Sex hormone replacement therapy reverses altered venous contractility in rats after pharmacological ovariectomy

S. Várbíró, Z. Vajó, G. Nádasy, E. Monos, N. Ács, Miklós Lóránt, James V. Felicetta, B. Székács

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Objective: Female sex hormones have several important effects on the venous system. We earlier found that hormone replacement has a significant effect on venous distensibility, but effects of menopause and hormone replacement on venous contractility have never been studied. Therefore, and because the changes we found earlier in distensibility were most likely caused by alterations of contractility, we examined the changes in contractility of saphenous vein caused by depletion and replacement of sex hormones in female rats. Design: Twenty Sprague-Dawley rats were pharmacologically ovariectomized by triptorelin. Ten of these rats received combined sex hormone replacement (HRT) with estradiol propionate and medroxyprogesterone acetate. The rest were given vehicle. Ten animals without ovariectomy served as controls. After 3 months of treatment, segments of the saphenous vein were dissected. Pressure-diameter curves were recorded in relaxed, contracted, and control states. Results: Venous diameter, adjusted for body weight, was significantly decreased after pharmacological ovariectomy. HRT increased the diameter. The presence of sex hormones augmented norepinephrine contraction measured at physiological pressures (control: 19.2 ± 2.3%; pharmacological ovariectomy: 15.2 ± 1.4%, p <0.05 and 17.8 ± 2.2% following HRT). Myogenic (spontaneous) tone of the saphenous vein did not change after ovariectomy, but it was lowered by hormone replacement (control: 8 ± 1.1%; ovariectomy: 6.9 ± 2.5%; ovariectomy + HRT: 2.7 ± 1.1%, p <0.05). Conclusions: Sex hormone depletion induces significant alterations in contractility of the saphenous vein, which could perturb venous capacitance function and distensibility. This effect has a potential role in the development of hypertension and venous varicosity, and these changes could possibly be prevented by HRT.

Original languageEnglish
Pages (from-to)122-126
Number of pages5
JournalMenopause
Volume9
Issue number2
Publication statusPublished - 2002

Fingerprint

Hormone Replacement Therapy
Gonadal Steroid Hormones
Ovariectomy
Hormones
Pharmacology
Saphenous Vein
Triptorelin Pamoate
Pressure
Medroxyprogesterone Acetate
Propionates
Menopause
Sprague Dawley Rats
Estradiol
Norepinephrine
Body Weight
Hypertension

Keywords

  • Contractility
  • Estrogen
  • Hormone replacement therapy
  • Progesterone
  • Vein

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

Sex hormone replacement therapy reverses altered venous contractility in rats after pharmacological ovariectomy. / Várbíró, S.; Vajó, Z.; Nádasy, G.; Monos, E.; Ács, N.; Lóránt, Miklós; Felicetta, James V.; Székács, B.

In: Menopause, Vol. 9, No. 2, 2002, p. 122-126.

Research output: Contribution to journalArticle

@article{b438bea849d040a3adc849e4bcffe65d,
title = "Sex hormone replacement therapy reverses altered venous contractility in rats after pharmacological ovariectomy",
abstract = "Objective: Female sex hormones have several important effects on the venous system. We earlier found that hormone replacement has a significant effect on venous distensibility, but effects of menopause and hormone replacement on venous contractility have never been studied. Therefore, and because the changes we found earlier in distensibility were most likely caused by alterations of contractility, we examined the changes in contractility of saphenous vein caused by depletion and replacement of sex hormones in female rats. Design: Twenty Sprague-Dawley rats were pharmacologically ovariectomized by triptorelin. Ten of these rats received combined sex hormone replacement (HRT) with estradiol propionate and medroxyprogesterone acetate. The rest were given vehicle. Ten animals without ovariectomy served as controls. After 3 months of treatment, segments of the saphenous vein were dissected. Pressure-diameter curves were recorded in relaxed, contracted, and control states. Results: Venous diameter, adjusted for body weight, was significantly decreased after pharmacological ovariectomy. HRT increased the diameter. The presence of sex hormones augmented norepinephrine contraction measured at physiological pressures (control: 19.2 ± 2.3{\%}; pharmacological ovariectomy: 15.2 ± 1.4{\%}, p <0.05 and 17.8 ± 2.2{\%} following HRT). Myogenic (spontaneous) tone of the saphenous vein did not change after ovariectomy, but it was lowered by hormone replacement (control: 8 ± 1.1{\%}; ovariectomy: 6.9 ± 2.5{\%}; ovariectomy + HRT: 2.7 ± 1.1{\%}, p <0.05). Conclusions: Sex hormone depletion induces significant alterations in contractility of the saphenous vein, which could perturb venous capacitance function and distensibility. This effect has a potential role in the development of hypertension and venous varicosity, and these changes could possibly be prevented by HRT.",
keywords = "Contractility, Estrogen, Hormone replacement therapy, Progesterone, Vein",
author = "S. V{\'a}rb{\'i}r{\'o} and Z. Vaj{\'o} and G. N{\'a}dasy and E. Monos and N. {\'A}cs and Mikl{\'o}s L{\'o}r{\'a}nt and Felicetta, {James V.} and B. Sz{\'e}k{\'a}cs",
year = "2002",
language = "English",
volume = "9",
pages = "122--126",
journal = "Menopause",
issn = "1072-3714",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Sex hormone replacement therapy reverses altered venous contractility in rats after pharmacological ovariectomy

AU - Várbíró, S.

AU - Vajó, Z.

AU - Nádasy, G.

AU - Monos, E.

AU - Ács, N.

AU - Lóránt, Miklós

AU - Felicetta, James V.

AU - Székács, B.

PY - 2002

Y1 - 2002

N2 - Objective: Female sex hormones have several important effects on the venous system. We earlier found that hormone replacement has a significant effect on venous distensibility, but effects of menopause and hormone replacement on venous contractility have never been studied. Therefore, and because the changes we found earlier in distensibility were most likely caused by alterations of contractility, we examined the changes in contractility of saphenous vein caused by depletion and replacement of sex hormones in female rats. Design: Twenty Sprague-Dawley rats were pharmacologically ovariectomized by triptorelin. Ten of these rats received combined sex hormone replacement (HRT) with estradiol propionate and medroxyprogesterone acetate. The rest were given vehicle. Ten animals without ovariectomy served as controls. After 3 months of treatment, segments of the saphenous vein were dissected. Pressure-diameter curves were recorded in relaxed, contracted, and control states. Results: Venous diameter, adjusted for body weight, was significantly decreased after pharmacological ovariectomy. HRT increased the diameter. The presence of sex hormones augmented norepinephrine contraction measured at physiological pressures (control: 19.2 ± 2.3%; pharmacological ovariectomy: 15.2 ± 1.4%, p <0.05 and 17.8 ± 2.2% following HRT). Myogenic (spontaneous) tone of the saphenous vein did not change after ovariectomy, but it was lowered by hormone replacement (control: 8 ± 1.1%; ovariectomy: 6.9 ± 2.5%; ovariectomy + HRT: 2.7 ± 1.1%, p <0.05). Conclusions: Sex hormone depletion induces significant alterations in contractility of the saphenous vein, which could perturb venous capacitance function and distensibility. This effect has a potential role in the development of hypertension and venous varicosity, and these changes could possibly be prevented by HRT.

AB - Objective: Female sex hormones have several important effects on the venous system. We earlier found that hormone replacement has a significant effect on venous distensibility, but effects of menopause and hormone replacement on venous contractility have never been studied. Therefore, and because the changes we found earlier in distensibility were most likely caused by alterations of contractility, we examined the changes in contractility of saphenous vein caused by depletion and replacement of sex hormones in female rats. Design: Twenty Sprague-Dawley rats were pharmacologically ovariectomized by triptorelin. Ten of these rats received combined sex hormone replacement (HRT) with estradiol propionate and medroxyprogesterone acetate. The rest were given vehicle. Ten animals without ovariectomy served as controls. After 3 months of treatment, segments of the saphenous vein were dissected. Pressure-diameter curves were recorded in relaxed, contracted, and control states. Results: Venous diameter, adjusted for body weight, was significantly decreased after pharmacological ovariectomy. HRT increased the diameter. The presence of sex hormones augmented norepinephrine contraction measured at physiological pressures (control: 19.2 ± 2.3%; pharmacological ovariectomy: 15.2 ± 1.4%, p <0.05 and 17.8 ± 2.2% following HRT). Myogenic (spontaneous) tone of the saphenous vein did not change after ovariectomy, but it was lowered by hormone replacement (control: 8 ± 1.1%; ovariectomy: 6.9 ± 2.5%; ovariectomy + HRT: 2.7 ± 1.1%, p <0.05). Conclusions: Sex hormone depletion induces significant alterations in contractility of the saphenous vein, which could perturb venous capacitance function and distensibility. This effect has a potential role in the development of hypertension and venous varicosity, and these changes could possibly be prevented by HRT.

KW - Contractility

KW - Estrogen

KW - Hormone replacement therapy

KW - Progesterone

KW - Vein

UR - http://www.scopus.com/inward/record.url?scp=0036188048&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036188048&partnerID=8YFLogxK

M3 - Article

VL - 9

SP - 122

EP - 126

JO - Menopause

JF - Menopause

SN - 1072-3714

IS - 2

ER -